There are contradictions among health officials about whether the newly approved Oxford-AstraZeneca COVID-19 vaccine should be given to people 65 and older. Abigail Bimman reports on the confusion, as provinces expand vaccination efforts.
- AstraZeneca vaccine ‘still a win,’ needs better promotion by officials: experts
- Canada adds over 2,500 new coronavirus cases as vaccine rollout takes shape
- AstraZeneca’s COVID-19 vaccine not recommended for people in Canada over age 65: NACI